Migraine Sufferers May Benefit From Closure Of Patent Foramen Ovale

Main Category: Headache / Migraine
Also Included In: Neurology / Neuroscience;  Stroke
Article Date: 17 Feb 2009 - 5:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Reducing the frequency and severity of disabling migraines is crucial for quality of life. A new study, published in the February 2009 issue of JACC: Cardiovascular Interventions, finds significant improvement of migraine following catheter-based closure of patent foramen ovale (PFO) - a slight opening in the wall between the right and left atria.

These findings confirm those of previous observational studies, which consistently show that when a PFO is closed - whether it's following a stroke or decompression illness - migraine also tends to improve in the majority of cases (approximately 75 percent). However, the present study was the first to enroll patients with severe migraine, a large PFO and no history of stroke or transient ischemic attacks, but with silent brain lesions on magnetic resonance imaging.

"The study suggests closure of a large PFO may improve migraine in patients with subclinical brain lesions, as well as those with prior stroke," says Carlo Vigna, M.D., of Casa Sollievo della Sofferenza IRCCS Hospital, San Giovanni Rotondo, Italy. "In the past, the beneficial effect on migraine was occasionally seen after PFO closure was performed for other reasons, for example, unexplained stroke. Conversely, the recently published MIST trial did not show significant improvement of symptoms in 'pure migraneurs' in the absence of symptomatic or subclinical cerebral ischemia. As compared with these two extremes, we enrolled patients with an intermediate subset of characteristics."

Patients were divided into either the closure (n=53) or control (n=29) group based on their consent to undergo percutaneous PFO closure, and prospectively examined for 6 months. Compared with the medically treated control group, closure of a PFO resulted in greater numbers of patients who had cessation of migraine attacks, cessation of disabling attacks and over 50 percent reduction in migraine attacks.

While this may be good news for certain migraine sufferers, researchers say a larger randomized trial focusing on this patient population is needed. In addition, the relationship between PFO and migraine must be further examined and understood.

"We don't really know what's going on. A stroke could be caused if a blood clot passes across a PFO and travels to the brain, but with migraine we don't yet know what the trigger substance is that crosses the shunt," says Dr. Peter Wilmshurst, Royal Shrewsbury Hospital, United Kingdom. "Not everyone with migraine has a PFO, and not everyone with a PFO has migraine; there are other causes that we don't yet understand."

Background: It is widely accepted that migraine is associated with higher rates of stroke. Research also suggests that people with migraine also have a higher prevalence of right-to-left shunts on contrast echocardiograms, which are, by and large, due to PFO - something each of us has while in the womb to divert blood away from the lungs. However, for one in four people, a hole remains after birth.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

The American College of Cardiology is leading the way to optimal cardiovascular care and disease prevention. The College is a 36,000-member nonprofit medical society and bestows the credential Fellow of the American College of Cardiology upon physicians who meet its stringent qualifications. The College is a leader in the formulation of health policy, standards and guidelines, and is a staunch supporter of cardiovascular research. The ACC provides professional education and operates national registries for the measurement and improvement of quality care. More information about the association is available online at http://www.acc.org/.

The American College of Cardiology (ACC) provides these news reports of clinical studies published in the Journal of the American College of Cardiology as a service to physicians, the media, the public and other interested parties. However, statements or opinions expressed in these reports reflect the view of the author(s) and do not represent official policy of the ACC unless stated so.

Source: Amanda Jekowsky
American College of Cardiology